Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors
Clinical trial NCT06054932 · UNKNOWN
Trial details
- NCT number
- NCT06054932
- Sponsor
- Beijing Likang Life Science and Tech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-05
- Primary completion
- 2025-12-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.